Dr. Johnson’s research work is focused on the early identification of infants at high risk for the development of cerebral palsy and other neurodevelopmental disorders. Her KL2 Mentored Research Career Development Award project will transform current clinical practice at Arkansas Children’s Hospital by implementing the General Movement Assessment, a low-cost diagnostic tool, to identify Neurodevelopmental Disabilities […]
Jesús Delgado-Calle, Ph.D.
The Delgado-Calle laboratory focuses on understanding the mechanisms by which cancer cells alter the biology of other cells in the tumor/bone marrow microenvironment, in particular osteocytes, with the final goal of identifying targetable factors for the treatment of cancer that grows in bone. We employ ex vivo and in vitro models to study osteocyte-tumor biology, […]
Fenghuang (Frank) Zhan, PhD
Dr. Zhan is interested in understanding how the genetic alterations in cancer cells contribute to tumor progression, alter treatment response and create vulnerabilities that may be targeted therapeutically.
Isabelle Racine Miousse, Ph.D.
Dr. Racine Miousse specializes in epigenetics, with a focus on how environmental factors linked to cancer affect DNA and histone methylation. I investigate how the supply and metabolism of the methyl donor methionine modulates these responses and alters cancer development. My current project studies how to modulate dietary methionine to alter autophagy and improve the […]
Abdelrahman (Abdel) Y. Fouda, B.Pharm., Ph.D.
Our lab studies central nervous system (CNS) injury mainly in the retina and brain. The lab employs different molecular/cell culture techniques, human tissue samples, and animal studies to model critical disease conditions in these two organs. Among the diseases under study are diabetic retinopathy, retinopathy of prematurity, traumatic optic neuropathy, traumatic brain injury, and stroke. […]
Alicia Byrd, Ph.D.
Dr. Byrd’s research aims to characterize the molecular mechanisms of helicases involved in regulation of the DNA damage response using biochemical, biophysical, and systems biology approaches with the overall goal of designing better cancer treatments.
Boris Zybaylov, Ph.D.
I am interested in the role of non-canonical DNA structures and long non-coding RNAs in human disease. I am also interested in clinical applications of microbiome-derived protein biomarkers
Amanda Stolarz, Pharm.D., Ph.D.
My research interest is focused on learning the techniques and approaches that underscore hypothesis-driven basic and translational cardiovascular/lymphatic pharmacology research. The primary focus is the mechanisms of damage to the lymphatic system during cancer chemotherapy and developing therapeutic strategies to reduce this damage. The laboratory uses techniques such as tissue dissection, enzymatic cell isolation, flow […]
Zhiqiang Qin, M.D., Ph.D.
Dr. Qin’s research focuses on cancer oncology and microbiology. He has an active NIH/NCI research award titled Periodontal Bacteria Enhance Oral KSHV Pathogenesis and Kaposi’s Sarcoma Development in HIV+ Patients.
Nirmala Parajuli, D.V.M, Ph.D.
The long-term interest of my laboratory is to understand molecular mechanisms responsible for cold storage (CS)-induced renal damage. My research focuses on exploring novel mechanisms by which CS alters protein quality and renal function after transplantation, and importantly, to identify a possible therapeutic target that could lead to improved renal outcome after transplantation. Specifically, I […]